There could be a link between your semaglutide use and your serious health complication, and you might be able to use legal action to try to set things right
Wegovy joins Rezdiffra (resmetirom), which is a thyroid hormone receptor (THR)-beta agonist, as another FDA-approved medication for treating MASH
C., Consoli, A., et al
Clinical trial data indicates tesofensine-induced weight loss consists predominantly of fat mass loss with notable preservation of lean body mass, a critical distinction from general caloric restriction which typically results in proportional loss of both fat and muscle tissue
For example, nausea occurred in about 20% of tirzepatide patients versus 18% with semaglutide
Other risks of surgery include, but are not limited to, post-operative pneumonia, heart attack, stroke, blood clots in the legs and sometimes in the lungs, organ failure, and even death